, Dec. 23, 2019
/PRNewswire-PRWeb/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, announced the completion of the first surgery using the recently FDA cleared Persona Revision Knee System for a revision knee arthroplasty procedure. The case was performed by David Lewallen
, MD in Rochester, Minnesota
"This is a very intuitive, elegant and powerful revision system," said David Lewallen
, MD. "Used with cemented stems it is also quite simple, with limited instrumentation and very adaptable to a wide range of patient anatomic variations and bone defects."
The Persona Revision Knee System offers anatomic implant geometry to achieve the desired bone coverage, fixation1 and stability to provide patients an individualized implant fit to personalize revision knee arthroplasty based on patient anatomy.
"This system has been meticulously designed and tested to deliver a revision solution of the highest quality, that addresses the varying and sometimes unpredictable challenges surgeon customers encounter," said Jim Lancaster
, Group President, Joint Reconstruction at Zimmer Biomet. "We are proud to offer the orthopedic community such a system and look forward to learning how it has helped improve patient lives."
For more information about the Persona Revision Knee System, visit us on the web at http://www.zimmerbiomet.com.
References: 1. Data on File at Zimmer Biomet. Zimmer ZTR_BI_0245_18. 2018.
Triathlon® is a trademark of Stryker Corporation or its affiliates.
SOURCE Zimmer Biomet